MSB 7.69% $1.19 mesoblast limited

MSB Trading 2020 - a new dawn, page-7681

  1. 762 Posts.
    lightbulb Created with Sketch. 524
    Mesoblast will urgently request a Type A meeting with the FDA, expected within 30 days, to discuss a potential accelerated approval with a post-approval condition for an additional study.

    Am i reading this wrong or is it a distinct possibility we'll have approval in a bit over 30 days?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.